Biography

Dr. Newton is originally from a small town in North Texas. He moved Denton, Texas to obtain his undergraduate degree from the University of North Texas. He then stayed in the Dallas-Fort Worth area to attend medical school at the University of Texas Southwestern Medical Center, where he then continued his training completing his residency in Internal Medicine and his fellowship in Pulmonary and Critical Care. During his training he served as Chief Resident for the UTSW Department of Internal Medicine and Chief Fellow for the UTSW Division of Pulmonary and Critical Care. While in fellowship, Dr. Newton developed a clinical and research interest in the interstitial lung diseases. With his research, he hopes to expand our understanding of the clinical and molecular risk factors that lead to the development and progression of these diseases.  Dr. Newton has an active practice in the UT Southwestern Advanced Lung Disease Clinic where he cares for patients with various forms of interstitial lung disease. Dr. Newton is board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine by the American Board of Internal Medicine. 

Education

Medical School
UT Southwestern Medical School (2009)
Residency
UT Southwestern Medical Center (2013), Internal Medicine
Fellowship
UT Southwestern Medical Center (2017), Pulmonary Diseases & Critical Care Medicine

Clinical Interest

Interstitial Lung Disease (Pulmonary Fibrosis)

  • Alveolar Hemorrhage Syndrome
  • Bronchiolitis Obliterans
  • Bronchiolitis Obliterans Organizing Pneumonia (BOOP)
  • Connective Tissue Disease
  • Desquamative Interstitial Pneumonia
  • Drug Induced Lung Disease
  • Eosinophilic Granuloma
  • Hyper IgE Syndrome with Lung Disease
  • Idiopathic Fibrosing Alveolitis
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Interstitial Lung Disease (ILD)
  • Interstitial Pneumonitis
  • Lymphocytic Interstitial Pneumonia
  • Organizing Pneumonia
  • Polymyositis
  • Post Inflammatory Pulmonary Fibrosis
  • Pulmonary Vasculitis
  • Relapsing Polychondritis
  • Respiratory Bronchiolitis with Interstital Lung Disease
  • Restrictive Lung Disease
  • Scleroderma - Pulmonary Complications
  • Sjogren's Disease - Pulmonary Complications
  • Wegener's Granulomatosis

Occupational/Environmental Lung Disease

  • Asbestosis
  • Berylliosis
  • Coal Worker's Pneumoconiosis
  • Hypersensitivity Pneumonia
  • Occupational Asthma
  • Pneumoconiosis
  • Silicosis

Research Interest

  • Chronic Hypersensitivity Pneumonitis
  • Clinical Outcomes of Patients with Interstitial Lung Disease
  • Conncective Tissue Disease Associated Interstitial Lung Disease
  • Familial Pulmonary Fibrosis
  • Genetic Determinants of Interstitial Lung Disease
  • Idiopathic Interstitial Pneumonia
  • Idiopathic Pulmonary Fibrosis
  • Interstitial Lung Disease
  • Telomere Dysfunction

Publications

Featured Publications LegendFeatured Publications

Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.
Newton CA, Kozlitina J, Lines JR, Kaza V, Torres F, Garcia CK J. Heart Lung Transplant. 2017 Aug 36 8 845-853
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B, Newton CA, Arnould I, Elicker BM, Henry TS, Vittinghoff E, Golden JA, Jones KD, Batra K, Torrealba J, Garcia CK, Wolters PJ Lancet Respir Med 2017 Aug 5 8 639-647
Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations.
Newton CA, Batra K, Torrealba J, Meyer K, Raghu G, Garcia CK Eur. Respir. J. 2017 May 49 5
Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations.
Maryoung L, Yue Y, Young A, Newton CA, Barba C, van Oers NS, Wang RC, Garcia CK J. Clin. Invest. 2017 Mar 127 3 982-986
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.
Newton CA, Batra K, Torrealba J, Kozlitina J, Glazer CS, Aravena C, Meyer K, Raghu G, Collard HR, Garcia CK Eur. Respir. J. 2016 Dec 48 6 1710-1720
Pulmonary fibrosis in the era of stratified medicine.
Mathai SK, Newton CA, Schwartz DA, Garcia CK Thorax 2016 Dec 71 12 1154-1160
Pirfenidone for Idiopathic Pulmonary Fibrosis.
Adams TN, Eiswirth C, Newton CA, Battaile JT Am. J. Respir. Crit. Care Med. 2016 Aug 194 3 374-6

Honors & Awards

  • Chief Fellow, Pulmonary & Critical Care Medicine
    UT Southwestern (2015-2016)
  • Chief Resident, Internal Medicine
    UT Southwestern (2012-2013)
  • Intern Teaching Award
    UT Southwestern Internal Medicine Residency Program (2010)
  • Hemphill-Gojer Internal Medicine Award
    UT Southwestern Medical School (2009)
  • Vanetta, Hesser, Schmalstieg Excellence in Tutoring Award
    UT Southwestern Medical School (2009)
  • Alpha Omega Alpha Honor Society
    UT Southwestern Medical School Chapter (2008)

Professional Associations/Affiliations

  • American College of Chest Physicians (2013)
  • American Thoracic Society (2012)
  • American Medical Association (2009)
  • Dallas County Medical Society (2009)
  • Texas Medical Association (2009)